Invitation
| Dokumendiregister | Rahandusministeerium |
| Viit | 1.5-12/1861-1 |
| Registreeritud | 27.04.2026 |
| Sünkroonitud | 28.04.2026 |
| Liik | Sissetulev kiri |
| Funktsioon | 1.5 DOKUMENDIHALDUS JA ASJAAJAMISE KORRALDAMINE |
| Sari | 1.5-12 Kutsed ja kirjavahetus seminaridel, konverentsidel jt üritustel osalemiseks |
| Toimik | 1.5-12/2026 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | Politico |
| Saabumis/saatmisviis | Politico |
| Vastutaja | Martin Põder (Rahandusministeerium, Kantsleri vastutusvaldkond, Euroopa Liidu ja rahvusvahelise koostöö osakond) |
| Originaal | Ava uues aknas |
Failid
|
Tähelepanu!
Tegemist on välisvõrgust saabunud kirjaga. |
Silvia Mangia
|
Event Marketing Data Specialist
[email protected] |
+32 2 548 15 38
Rue de la Loi 62, 1040 Brussels, Belgium
10 years of POLITICO in Europe — stay ahead with the Brussels
Playbook, trusted by 140,000+ readers.
_________________________________________________________
The information contained in this message is likely to be confidential and is intended for the addressee only. Any unauthorized use, dissemination of the information or copying of this message is prohibited. If you are not the address you must not take any action in reliance on the content of this mail. Please notify the sender immediately by return email and delete this message
POLITICO SRL – Forme sociale : société privée à responsabilité limitée Numéro d’entreprise : 0526.900.436 RPM Brussels - Numéro de TVA : BE 0526.900.436 Siège social : Rue de la Loi 62. 1040 Brussels, Belgium Tel: +32-2 540.90.90. Fax: + 32-2 540.90.70 - www.politico.eu
March 13, 2026
Invitation from POLITICO
Competitive Europe Salon Dinner | May 5 | Brussels
We are delighted to invite you to join us at our Competitive Europe Salon Dinner presented
by Bayer, scheduled for Tuesday, May 5 in Brussels.
This salon dinner offers a distinctive opportunity to exchange strategic perspectives on how the
European pharmaceutical sector can ensure it remains competitive amid a rapidly evolving geopolitical landscape. It will also provide a forum to engage with senior policymakers and
industry leaders on how the EU and its member states can further advance innovation,
strengthen resilience and reinforce Europe’s leadership in the global pharmaceutical arena.
We would be honored by your presence at this special dinner dialogue and value your
contributions to what is shaping up to be an enlightening evening.
If you have any further questions about the event, please contact [email protected]
Yours sincerely,
Carrie Budoff Brown Executive Editor and Vice President
POLITICO
POLITICO SRL – Forme sociale : société privée à responsabilité limitée Numéro d’entreprise : 0526.900.436 RPM Brussels - Numéro de TVA : BE 0526.900.436 Siège social : Rue de la Loi 62. 1040 Brussels, Belgium Tel: +32-2 540.90.90. Fax: + 32-2 540.90.70 - www.politico.eu
The topic for discussion
A competitive European Pharmaceutical sector in a changing geopolitical landscape
European health and social care systems are under intense pressure. Aging populations and
increasing rates of chronic diseases are straining public health budgets. At the same time, Europe
faces unprecedented geopolitical challenges and competing demands for public finances.
European policymakers are looking to find new approaches to revitalize the health care sector.
How should health systems adapt? How do geopolitical tensions affect the future of the
pharmaceutical sector within Europe? Where does the EU currently stand in the global innovation
race with the US and China? Is there an argument for a true EU single market for health products?
Which solutions can be provided at the EU level and what role can Member States play in
strengthening a resilient and competitive European Pharmaceutical sector? How can health
budget holders navigate current challenges and create room for strategic investments that improve health and reduce costs in the long term? Is Europe’s welfare state model at risk?
POLITICO SRL – Forme sociale : société privée à responsabilité limitée Numéro d’entreprise : 0526.900.436 RPM Brussels - Numéro de TVA : BE 0526.900.436 Siège social : Rue de la Loi 62. 1040 Brussels, Belgium Tel: +32-2 540.90.90. Fax: + 32-2 540.90.70 - www.politico.eu
March 13, 2026
Invitation from POLITICO
Competitive Europe Salon Dinner | May 5 | Brussels
We are delighted to invite you to join us at our Competitive Europe Salon Dinner presented
by Bayer, scheduled for Tuesday, May 5 in Brussels.
This salon dinner offers a distinctive opportunity to exchange strategic perspectives on how the
European pharmaceutical sector can ensure it remains competitive amid a rapidly evolving geopolitical landscape. It will also provide a forum to engage with senior policymakers and
industry leaders on how the EU and its member states can further advance innovation,
strengthen resilience and reinforce Europe’s leadership in the global pharmaceutical arena.
We would be honored by your presence at this special dinner dialogue and value your
contributions to what is shaping up to be an enlightening evening.
If you have any further questions about the event, please contact [email protected]
Yours sincerely,
Carrie Budoff Brown Executive Editor and Vice President
POLITICO
POLITICO SRL – Forme sociale : société privée à responsabilité limitée Numéro d’entreprise : 0526.900.436 RPM Brussels - Numéro de TVA : BE 0526.900.436 Siège social : Rue de la Loi 62. 1040 Brussels, Belgium Tel: +32-2 540.90.90. Fax: + 32-2 540.90.70 - www.politico.eu
The topic for discussion
A competitive European Pharmaceutical sector in a changing geopolitical landscape
European health and social care systems are under intense pressure. Aging populations and
increasing rates of chronic diseases are straining public health budgets. At the same time, Europe
faces unprecedented geopolitical challenges and competing demands for public finances.
European policymakers are looking to find new approaches to revitalize the health care sector.
How should health systems adapt? How do geopolitical tensions affect the future of the
pharmaceutical sector within Europe? Where does the EU currently stand in the global innovation
race with the US and China? Is there an argument for a true EU single market for health products?
Which solutions can be provided at the EU level and what role can Member States play in
strengthening a resilient and competitive European Pharmaceutical sector? How can health
budget holders navigate current challenges and create room for strategic investments that improve health and reduce costs in the long term? Is Europe’s welfare state model at risk?